Saksoft receives NCLT sanction for Augmento Labs amalgamation
- NCLT Chennai sanctioned the amalgamation of Augmento Labs into Saksoft on September 16, 2026
- The scheme's Appointed Date is fixed at April 1, 2026, to streamline group structure
- Total acquisition consideration of ₹97.5 crore for Augmento Labs was fully paid prior to merger
- Merger aims to reduce administrative costs and eliminate inter-corporate dependencies

*this image is generated using AI for illustrative purposes only.
Saksoft Limited has received sanction from the National Company Law Tribunal (NCLT), Chennai Bench, for the amalgamation of its wholly owned subsidiary, Augmento Labs Private Limited, with and into the company. The order was pronounced on September 16, 2026, marking a significant step in the company's corporate restructuring efforts.
The NCLT approved the Scheme of Amalgamation under Sections 230 to 232 of the Companies Act, 2013. The Appointed Date for the merger is set as April 1, 2026. The scheme will become effective upon the filing of the certified copy of the order with the Registrar of Companies, Chennai.
Strategic Rationale and Benefits
The primary objective of the amalgamation is to consolidate entities within the Saksoft group, thereby simplifying the holding structure by eliminating multiple legal entities. According to the scheme details, this move is expected to drive greater efficiency in the combined business through economies of scale and operational rationalization.
Key benefits highlighted in the filing include:
- Elimination of inter-corporate dependencies and duplication of activities.
- Reduction in administrative, managerial, and overhead costs.
- Minimization of multiplicity of legal and regulatory compliances.
- Enhanced cash flow management and unfettered access to funds for growth opportunities.
Accounting Treatment and Compliance
The transaction will be accounted for using the Pooling of Interest Method as prescribed in Ind AS 103 (Appendix C) for business combinations under common control. Upon the scheme becoming effective, all assets, liabilities, and reserves of Augmento Labs will vest in Saksoft. The shares of the transferor company held by Saksoft will stand cancelled without any further act or deed.
The NCLT noted that while the Regional Director raised certain observations regarding employee protection and appointed date clarity, the petitioners provided necessary undertakings. These include commitments not to alter the Appointed Date without tribunal approval and to ensure no retrenchment of employees in service as of the Appointed Date.
What the Numbers Show
A critical observation from the regulatory filings reveals that the acquisition consideration for Augmento Labs was determined on an arm's-length basis under a Share Purchase Agreement dated June 12, 2024. The total purchase price comprised an upfront payment of ₹35 crore and deferred earnout payments linked to financial performance parameters. The petitioners clarified that the entire consideration, including deferred amounts totaling ₹97.5 crore, has been paid in full. This confirms that the acquisition was complete prior to the merger sanction, ensuring that the amalgamation proceeds without additional cash outflow obligations for the transferee company.
Historical Stock Returns for Saksoft
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.38% | +3.89% | -9.62% | +23.60% | -29.92% | +88.36% |
How will the elimination of Augmento Labs' separate legal entity impact Saksoft's consolidated operating margins in the upcoming fiscal quarters?
What specific revenue synergies or cross-selling opportunities does Saksoft anticipate unlocking from integrating Augmento Labs' capabilities?
Will the simplified corporate structure enable Saksoft to pursue further acquisitions or strategic partnerships more aggressively?


































